Correlation Between Hain Celestial and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hain Celestial and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hain Celestial and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Hain Celestial and Integrated Biopharma, you can compare the effects of market volatilities on Hain Celestial and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hain Celestial with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hain Celestial and Integrated Biopharma.

Diversification Opportunities for Hain Celestial and Integrated Biopharma

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Hain and Integrated is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding The Hain Celestial and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Hain Celestial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Hain Celestial are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Hain Celestial i.e., Hain Celestial and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Hain Celestial and Integrated Biopharma

Given the investment horizon of 90 days The Hain Celestial is expected to under-perform the Integrated Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, The Hain Celestial is 2.19 times less risky than Integrated Biopharma. The stock trades about -0.03 of its potential returns per unit of risk. The Integrated Biopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  38.00  in Integrated Biopharma on August 28, 2024 and sell it today you would lose (5.00) from holding Integrated Biopharma or give up 13.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy31.52%
ValuesDaily Returns

The Hain Celestial  vs.  Integrated Biopharma

 Performance 
       Timeline  
Hain Celestial 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in The Hain Celestial are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile forward indicators, Hain Celestial may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Hain Celestial and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hain Celestial and Integrated Biopharma

The main advantage of trading using opposite Hain Celestial and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hain Celestial position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind The Hain Celestial and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges